Progyny, Inc. Executives to Participate in Upcoming Investor Conferences

Progyny, Inc. (Nasdaq: PGNY), a prominent leader in women's health and family building solutions, has announced that key executives will participate in several notable investor conferences throughout March 2026. This announcement underscores Progyny's commitment to transparency and stakeholder engagement. On March 10, Mark Livingston, the Chief Financial Officer, will engage in a fireside chat at the Leerink Partners Global Healthcare Conference, scheduled for 10:40 a.m. Eastern Time. The following day, Pete Anevski, the Chief Executive Officer, will discuss company insights during another fireside chat at the Barclays Global Healthcare Conference at 1:00 p.m. Eastern Time.

Additionally, Progyny's Chief Operating Officer, Melissa Cummings, will join a panel discussion focusing on fertility technology and women's health on March 17, 2026, at the KeyBanc Capital Markets Healthcare Forum, occurring at 12:00 p.m. Eastern Time. Later that same day, Anevski will participate in a second fireside chat at 3:00 p.m. Eastern Time. Investors and interested parties can access live audiocasts and replays of these discussions through Progyny's investor relations website.

Headquartered in New York City, Progyny is recognized for providing comprehensive and inclusive solutions that enhance the healthcare experience for women and families. Their benefits empower patients through concierge support, educational resources, and access to premier fertility specialists, all aimed at achieving optimal clinical outcomes and reducing costs. Progyny has earned accolades for its growth and leadership, including being recognized as a TIME100 Most Influential Company and a CNBC Disruptor 50.

For further information, interested parties are encouraged to visit Progyny's official website or contact their investor relations and media teams directly.

As Progyny, Inc. (Nasdaq: PGNY) prepares for a series of key investor conferences in March 2026, investors should closely monitor the insights presented by the company’s executive leadership. Progyny is a notable player in women’s health and family building solutions, recognized for its innovative approach and positive clinical outcomes.

Mark Livingston, Chief Financial Officer, will kick off the conference participation at the Leerink Partners Global Healthcare Conference on March 10th. His insights into the company's financial health and strategic direction will be crucial for potential and current investors to gauge Progyny’s positioning for future growth. The financial narrative set forth by Livingston may highlight revenue trends or cost-saving measures associated with their comprehensive benefits solutions.

Following this, CEO Pete Anevski’s participation at the Barclays Global Healthcare Conference on March 11th will provide a broader vision for the company. Anevski's leadership is pivotal in understanding the strategic initiatives the company intends to pursue, particularly in a competitive landscape where innovation is critical for capturing market share. His insights into strategic partnerships, market expansion, and product innovation could serve as indicators of Progyny's growth trajectory.

Moreover, COO Melissa Cummings will discuss the operational aspects of Progyny’s offerings at the KeyBanc Capital Markets Healthcare Forum. Her engagement in the panel discussion on fertility technology will provide investors with an overview of the company's operational efficiency and technological advancements, which are essential for enhancing patient engagement and improving health outcomes.

Given Progyny's accolades and recognition in the industry, their upcoming presentations may serve as a catalyst for further investor interest. Therefore, keeping an eye on the executives' messages during these conferences could yield valuable information for making informed investment decisions in this promising sector.